Search Results - "DANDEKAR, Prachi K"

Use of Monte Carlo Simulation to Design an Optimized Pharmacodynamic Dosing Strategy for Meropenem by Kuti, Joseph L., Dandekar, Prachi K., Nightingale, Charles H., Nicolau, David P.

“…Prolonging the infusion of meropenem over 3 hours increases the percentage of the dosing interval that drug concentrations remain above the minimum inhibitory…”
Get full text

Pharmacodynamic Profile of Telithromycin against Macrolide- and Fluoroquinolone-Resistant Streptococcus pneumoniae in a Neutropenic Mouse Thigh Model by TESSIER, Pamela R, MATTOES, Holly M, DANDEKAR, Prachi K, NIGHTINGALE, Charles H, NICOLAU, David P

“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text

Pharmacodynamic profile of daptomycin against Enterococcus species and methicillin-resistant Staphylococcus aureus in a murine thigh infection model by Dandekar, Prachi K., Tessier, Pamela R., Williams, Peter, Nightingale, Charlie H., Nicolau, David P.

“…Objective: To describe the pharmacodynamic profile of daptomycin against methicillin-resistant Staphylococcus aureus (MRSA) and Enterococci species based on…”
Get full text

Pharmacokinetics of Meropenem 0.5 and 2 g Every 8 Hours as a 3-Hour Infusion by Dandekar, Prachi K., Maglio, Dana, Sutherland, Christina A., Nightingale, Charles H., Nicolau, David P.

“…Study Objective. To assess the pharmacokinetics of meropenem administered as a 3‐hour infusion. Design. Randomized, crossover, open‐label study. Setting…”
Get full text

Assessment of the efficacy of telithromycin simulating human exposures against S. pneumoniae with ribosomal mutations in a murine pneumonia model by Dandekar, Prachi K., Williams, Peter, Tessier, Pamela R., Farrell, David J., Nightingale, Charles H., Nicolau, David P.

“…Telithromycin (TEL) is a ketolide antimicrobial agent with in vitro activity against Streptococcus pneumoniae (SPN), including macrolide resistant strains. The…”
Get full text

Pharmacodynamic considerations for the selection of oral cephalosporins in the treatment of rhinosinusitis by Dandekar, Prachi K., Nicolau, David P.

“…The elimination of an infection occurs when the antibiotic reaches the site of the pathogen in adequate concentrations for an appropriate length of time. To…”
Get full text

Evaluation of telithromycin against Streptococcus pneumoniae with ribosomal mutations utilizing in vitro time–kill methodology by Dandekar, Prachi K., Tessier, Pamela R., Farrell, David J., Nightingale, Charles H., Nicolau, David P.

“…In a recent study, our in vivo data suggested that clinically achievable levels of telithromycin are more effective than azithromycin against selected…”
Get full text

Prevalence of extended spectrum β-lactamase producing escherichia coli and klebsiella isolates in a large community teaching hospital in connecticut by Dandekar, Prachi K., Tetreault, Janice, Quinn, John P., Nightingale, Charles H., Nicolau, David P.

“…The prevalence of extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli (ESC) and Klebsiella (KS) among consecutive non-urine isolates were…”
Get full text

Determination of the pharmacodynamic profile of daptomycin against Streptococcus pneumoniae isolates with varying susceptibility to penicillin in a murine thigh infection model by Dandekar, Prachi K, Tessier, Pamela R, Williams, Peter, Zhang, Cuilian, Nightingale, Charlie H, Nicolau, David P

“…Daptomycin has demonstrated in vitro activity against gram-positive organisms, including Streptococcus pneumoniae. However, the pharmacodynamic (PD) profile of…”
Get more information

Extended-spectrum beta-lactamases (ESBL) by Dandekar, Prachi K, Quintiliani, Richard, Nightingale, Charles H, Nicolau, David P

Get more information

Utilization of extended-spectrum beta-lactamase (ESBL) detection systems in microbiology laboratories: survey of Connecticut hospitals from 1998-2002 by Dandekar, Prachi K, Barrett, Nancy L, Nightingale, Charles H, Nicolau, David P

“…There has been recent concern raised over the detection, prevalence, and clinical implications of infection with Escherichia coli and Klebsiella spp. which…”
Get more information